JTC Employer Solutions Trustee’s Amgen AMGN Stock Holding History

JTC Employer Solutions Trustee’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-232	Closed	-$56K	–	345
2023 Q3	$56K	Hold	232	–	–	0.01%	250
2023 Q2	$56K	Hold	232	–	–	0.01%	251
2023 Q1	$56K	Hold	232	–	–	0.01%	254
2022 Q4	$56K	Hold	232	–	–	﹤0.01%	256
2022 Q3	$56K	Buy	+232	New	+$56.2K	0.01%	204

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JTC Employer Solutions Trustee's AMGN Position: Q4 2023 in Review

JTC Employer Solutions Trustee sold out of Amgen (AMGN) in Q4 2023, closing a stake of 232 shares — an estimated $56K sold.

JTC Employer Solutions Trustee first reported a position in AMGN in Q3 2022 and held it in 5 quarters. The position peaked at $56K in Q3 2023. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

JTC Employer Solutions Trustee reported no remaining Amgen position as of Q4 2023 after selling out during the quarter.
JTC Employer Solutions Trustee sold 232 Amgen shares in Q4 2023, an estimated $56K.
JTC Employer Solutions Trustee first reported a position in Amgen in Q3 2022 and held it in 5 quarters.
JTC Employer Solutions Trustee's Amgen position peaked at $56K in Q3 2023.
2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on JTC Employer Solutions Trustee's 13F filing for Q4 2023, filed 16 Jan 2024.